Samrat Pharmachem Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 477.338 million compared to INR 303.555 million a year ago. Net income was INR 15.597 million compared to INR 3.934 million a year ago. Basic earnings per share from continuing operations was INR 5.05 compared to INR 1.27 a year ago. For the full year, total revenue was INR 1,794.806 million compared to INR 1,380.247 million a year ago. Net income was INR 53.331 million compared to INR 42.37 million a year ago. Basic earnings per share from continuing operations was INR 17.26 compared to INR 13.71 a year ago.